Preview Mode Links will not work in preview mode


Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Jan 6, 2020

Dr. Nader Pourhassan, is Director, President, and CEO, CytoDyn, a late-stage biotechnology company developing leronlimab (PRO 140), a targeted therapy with the potential to treat multiple diseases.  Nader highlights CytoDyn's ongoing clinical trial evaluating leronlimab for metastatic triple negative breast cancer (mTNBC) and the company's plans to submit a Biologics License Agreement (BLA) to the U.S. Food and Drug Administration (FDA) for leronlimab in combination with highly active antiretroviral therapy (HAART) to treat patients suffering from HIV.


#HIV  #mTNBC  #TNBC  #Leronlimab

Listen to the podcast here